FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1986859538> ?p ?o ?g. }

• W1986859538 endingPage "2251" @default.
• W1986859538 startingPage "2244" @default.
• W1986859538 abstract "The purpose of this study was to test the hypothesis that the neuroprotective compound CP101,606 will ameliorate the increase in lactate, retard the development of cytotoxic edema, and decrease the infarct volume after ischemic stroke.Seventeen adult cats were allocated to control (n = 7) and CP101,606-treated groups (n = 10). Transorbital middle cerebral artery occlusion was performed under anesthesia. Extracellular fluid lactate by microdialysis as well as infarct volume measurement by triphenyltetrazolium chloride (TTC)-stained section, with and without neuroprotective agents, was used to determine the value of these potential surrogate markers of ischemic damage.The control group showed an increased dialysate lactate (15.5% increase) at 30 minutes and a peak (332.0% increase) in dialysate lactate at 1 hour after middle cerebral artery occlusion compared with the drug-treated group. Significant differences between control and drug-treated groups were seen in the rate of fall of the apparent diffusion coefficient at both 1 and 5 hours. A close correlation was seen between the 1- and 5-hour apparent diffusion coefficient maps and the TTC-stained sections. There was a significantly smaller lesion in the CP101,606-treated group (62.9% reduction in infarct size compared with the control group; P < .001).CP101,606 ranks very highly among the current neuroprotection candidates for clinical trials, and its excellent safety record in both animals and phase II studies in conscious, moderate head injury patients suggests that it will be highly effective in human occlusive stroke." @default.
• W1986859538 created "2016-06-24" @default.
• W1986859538 creator A5008555480 @default.
• W1986859538 creator A5012303491 @default.
• W1986859538 creator A5022756872 @default.
• W1986859538 creator A5025124764 @default.
• W1986859538 creator A5030149006 @default.
• W1986859538 creator A5031263597 @default.
• W1986859538 creator A5054772948 @default.
• W1986859538 date "1997-11-01" @default.
• W1986859538 modified "2023-09-27" @default.
• W1986859538 title "Effect of CP101,606, a Novel NR2B Subunit Antagonist of the <i>N</i> -Methyl- <scp>d</scp> -Aspartate Receptor, on the Volume of Ischemic Brain Damage and Cytotoxic Brain Edema After Middle Cerebral Artery Occlusion in the Feline Brain" @default.
• W1986859538 cites W1863375292 @default.
• W1986859538 cites W1968928244 @default.
• W1986859538 cites W1973406433 @default.
• W1986859538 cites W1991840712 @default.
• W1986859538 cites W1996426651 @default.
• W1986859538 cites W1997415998 @default.
• W1986859538 cites W2002180317 @default.
• W1986859538 cites W2007618562 @default.
• W1986859538 cites W2011527331 @default.
• W1986859538 cites W2012555960 @default.
• W1986859538 cites W2030204664 @default.
• W1986859538 cites W2030591899 @default.
• W1986859538 cites W2045299855 @default.
• W1986859538 cites W2046763552 @default.
• W1986859538 cites W2050039091 @default.
• W1986859538 cites W2053324279 @default.
• W1986859538 cites W2056033965 @default.
• W1986859538 cites W2056826168 @default.
• W1986859538 cites W2058527474 @default.
• W1986859538 cites W2061457602 @default.
• W1986859538 cites W2070139095 @default.
• W1986859538 cites W2084944797 @default.
• W1986859538 cites W2085273994 @default.
• W1986859538 cites W2094749887 @default.
• W1986859538 cites W2123887304 @default.
• W1986859538 cites W2139748951 @default.
• W1986859538 cites W2323818720 @default.
• W1986859538 cites W2949574343 @default.
• W1986859538 doi "https://doi.org/10.1161/01.str.28.11.2244" @default.
• W1986859538 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9368572" @default.
• W1986859538 hasPublicationYear "1997" @default.
• W1986859538 type Work @default.
• W1986859538 sameAs 1986859538 @default.
• W1986859538 citedByCount "51" @default.
• W1986859538 countsByYear W19868595382012 @default.
• W1986859538 countsByYear W19868595382013 @default.
• W1986859538 countsByYear W19868595382014 @default.
• W1986859538 countsByYear W19868595382015 @default.
• W1986859538 countsByYear W19868595382016 @default.
• W1986859538 countsByYear W19868595382018 @default.
• W1986859538 countsByYear W19868595382019 @default.
• W1986859538 countsByYear W19868595382020 @default.
• W1986859538 countsByYear W19868595382021 @default.
• W1986859538 countsByYear W19868595382023 @default.
• W1986859538 crossrefType "journal-article" @default.
• W1986859538 hasAuthorship W1986859538A5008555480 @default.
• W1986859538 hasAuthorship W1986859538A5012303491 @default.
• W1986859538 hasAuthorship W1986859538A5022756872 @default.
• W1986859538 hasAuthorship W1986859538A5025124764 @default.
• W1986859538 hasAuthorship W1986859538A5030149006 @default.
• W1986859538 hasAuthorship W1986859538A5031263597 @default.
• W1986859538 hasAuthorship W1986859538A5054772948 @default.
• W1986859538 hasConcept C126322002 @default.
• W1986859538 hasConcept C126894567 @default.
• W1986859538 hasConcept C127413603 @default.
• W1986859538 hasConcept C141071460 @default.
• W1986859538 hasConcept C164705383 @default.
• W1986859538 hasConcept C25498285 @default.
• W1986859538 hasConcept C2779493303 @default.
• W1986859538 hasConcept C2780645631 @default.
• W1986859538 hasConcept C2780886150 @default.
• W1986859538 hasConcept C2781156865 @default.
• W1986859538 hasConcept C42219234 @default.
• W1986859538 hasConcept C50156730 @default.
• W1986859538 hasConcept C529278444 @default.
• W1986859538 hasConcept C541997718 @default.
• W1986859538 hasConcept C71924100 @default.
• W1986859538 hasConcept C78519656 @default.
• W1986859538 hasConcept C98274493 @default.
• W1986859538 hasConceptScore W1986859538C126322002 @default.
• W1986859538 hasConceptScore W1986859538C126894567 @default.
• W1986859538 hasConceptScore W1986859538C127413603 @default.
• W1986859538 hasConceptScore W1986859538C141071460 @default.
• W1986859538 hasConceptScore W1986859538C164705383 @default.
• W1986859538 hasConceptScore W1986859538C25498285 @default.
• W1986859538 hasConceptScore W1986859538C2779493303 @default.
• W1986859538 hasConceptScore W1986859538C2780645631 @default.
• W1986859538 hasConceptScore W1986859538C2780886150 @default.
• W1986859538 hasConceptScore W1986859538C2781156865 @default.
• W1986859538 hasConceptScore W1986859538C42219234 @default.
• W1986859538 hasConceptScore W1986859538C50156730 @default.
• W1986859538 hasConceptScore W1986859538C529278444 @default.
• W1986859538 hasConceptScore W1986859538C541997718 @default.
• W1986859538 hasConceptScore W1986859538C71924100 @default.
• W1986859538 hasConceptScore W1986859538C78519656 @default.
• W1986859538 hasConceptScore W1986859538C98274493 @default.

• next